港股異動︱建滔集團(0148.HK)大漲逾7% 擬回購最多1.08億股
格隆匯9月26日丨建滔集團(00148.HK)盤初大幅拉昇至7.5%,報21.5港元,暫成交1351.9萬港元,最新總市值232.9億港元。建滔集團(00148.HK)昨日發佈公告,自今天起開始在香港聯合交易所有限公司購回公司股份。公司預計進行建議股份購回可持續數月,但視市場及其他狀況而定。公司獲授權最多於聯交所購回1.08億股股份。25日回購19.60萬股,耗資391.74萬港幣。公司認為,公司股份的價值一直被低估,現時成交價並不反映其內在價值。此外,9月以來公司股份獲執董張廣軍連續增持。值得注意的是,公司2019年上半年淨利潤同比降65.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.